Dopamine AND PD.

Slides:



Advertisements
Similar presentations
Chapter 5 Opener. 5.1 Structural features of catecholamines.
Advertisements

Dopamine Theory of Schizophrenia
Neurotransmitters Many Neurotransmitters (NT) exist: -Dopamine -Adrenaline -Serotonin -Acetylcholine Drugs can either: –Increase the effect of certain.
Drugs Used to Treat Parkinson’s Disease By Jasmine and Morgan 11/13/03.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
B 尤思涵. Dopamine and Serotonin Dopamine 4-(2-aminoethyl)benzene-1,2-diol 5-Hydroxytryptamine or 3-(2-aminoethyl)-1H-indol-5-ol Serotonin.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Schizophrenia The Unwell Brain. Disturbance in the Neurochemistry  The first discovery in the mid 1950s was that chronic usage of large daily doses of.
DR AMINA TARIQ BIOCHEMISTRY
PHAR2811 Lecture Amino acids as drug targets COMMONWEALTH OF AUSTRALIA Copyright Regulation WARNING This material has been reproduced and communicated.
NEUROCHEMICAL EFFECTS OF STIMULANTS: Relation to their motor effects.
GABA and Glycine: recap Inhibitory neurotransmitters Synthesis and packaging into vesicles. Removal from synapse Date-rape drug: gamma-hydroxybutyrate.
Neurotransmitters, Parkinson’s disease and depression
Neurotransmitters: Catecholamines & Acetylcholine Chapters 5 & 6
Copyright © 2009 Allyn & Bacon Chemicals That Harm with Pleasure This multimedia product and its contents are protected under copyright law. The following.
Psychopharmacology Inmaculada Ibanez-Casas, PhD
Limitation of animal models in drug discovery and development Candice Tahimic, Ph.D. Hence, there is a need to use human cells to test the efficacy of.
Synaptic Transmission How a neuron communicates with another neuron and the effects of drugs on this process. Types of Neurotransmitters.
23 كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، 1623 كانون الثاني، كانون الثاني، كانون الثاني،
Dopamine by Leila Burridge and Emily Little. Dopamine and It’s Uses ●Neurotransmitter ●Helps transmit signals in brain and other vital areas ●Found in.
DHBR NADP + NADPH from phe, diet, or protein breakdown Tyrosine L-Dopa H2OH2O O2O2 Tyrosine hydroxylase (rate-determining step) BH 2 BH 4 1 Dopa decarboxylase.
Dopamine in CNC Abdulelah Nuqali Intern. Overview Introduction Biochemistry Dopamine receptors Dopaminergic pathways Summary 2.
ANTI- PARKINSONISM Dr: Samah Gaafar Al-shaygi.  Neurodegenerative diseases.  Dopamenergic neurones in substantia nigra.  Environmental* genetic factors.
 Parkinson’s disease is a neurodegenerative disorder first described by Dr James Parkinson, a London physician, in The underlying cause is loss.
Dopamine: A Transmitter of Motion and Motivation Margaret E. Rice, Ph.D. Department of Neurosurgery Department of Physiology and Neuroscience Druckenmiller.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pharmacological Treatment of Parkinson Disease: A.
Neurochemistry of executive functions
Parkinson’s Disease.
Neurobiological Theories of Mental Disorders
18.4 Neurotransmitters A neurotransmitter is a chemical compound that transmits an impulse from a nerve cell to a target cell. Target cells may be another.
E. Dopaminergic neurons are located in the midbrain and hypothalamus
By the end of this section you will be able to …..
Dopamine system: neuroanatomy
E. Dopaminergic neurons are located in the midbrain and hypothalamus
What are the current guidelines for healthy living
Lecture 3 Dr.Narmin Hussen
E. Dopaminergic neurons are located in the midbrain and hypothalamus
Metabotropic Neurotransmitter Receptors
By: Kettle, Milner, Doucette
Nitric Oxide (NO) and How it Regulates Motor Function
Treatment of Parkinson’s disease
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Chapter 45: Endocrine System
Parkinson’s disease.
ANTIPARKINSONS Drugs By Dr. Mirza Shahed Baig.
Seratonin and Dopamine in the CNS
Neurotransmitters (NT)
Parkinson’s Common neurodegenerative disorder ~10-20/1000
Neurotransmitters Domina Petric, MD.
Central Nervous System
HuBio 543 September 25, 2007 Neil M. Nathanson K-536A, HSB
Neurotransmitters.
According to the Specification you need to be able to :
Basal ganglia function
Hormones and the Endocrine System
Anti-parkinsonism Drugs
Dopamine pathways & antipsychotics
Anti-parkinsonism Drugs
What are the current guidelines for healthy living
Parkinson's Disease Neuron
Eleanor H. Simpson, Christoph Kellendonk, Eric Kandel  Neuron 
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Neurotransmitters.
Drugs and the brain WB, JM, EW, BB.
Notes Ch. 11g Nervous System II.
Neurotransmitters and the Synapse
Sympathomimetics or Adrenergic Drugs
ANATOMY & PHYSIOLOGY Cell Signaling With a G-Protein Linked Receptor.
Presentation transcript:

Dopamine AND PD

Introduction Belongs to the family of catecholamine's Dopamine can be further converted into the hormones epinephrine and norepinephrine (also catecholamine’s) Plays a role in regulation of hormones, motor control and learning Found in humans, animals- both vertebrates and invertebrates

Production Produced in the substantia nigra and the ventral tegmental area It is a neurohormone and is released by the hypothalamus

Dopamine Receptors Two classes: D1-like receptor class - D1 (locomotion, reward, etc.) and D5 (Learning and memory) receptor subtypes Activates adenylyl cyclase which leads to increase in concentration of cAMP D2- like receptor class – D2 (locomotion, learning, etc.), D3 (cognition and emotion) and D4 (mostly unknown, possibly cognition) receptor subtypes Inhibits adenylyl cyclase leading to decrease in concentration of cAMP Have similar signaling properties, however have different signal transduction pathways They are G protein-coupled receptors, signaling mediated by interaction with GTP- binding proteins

Dopamine Pharmacology Can be used as an injectable drug Intropin, Dopastat, Revimine used in the treatment of severe hypotension, bradycardia (slow heart rate), circulatory shock, or cardiac arrest Toxicty-LD50-59mg/kg

L-DOPA Levodopa- dopamine precursor to treat Parkinson’s Disease and dopa-responsive Dystonia Typically co-administered with an inhibitor of peripheral decarboxylation Inhibitors of alternative metabolic route for dopamine by catechol-O-methyl transferase are also used These include entacapone and tolcapone.

Psychostimulants Cocaine and substituted amphetamines all increase dopamine neuronal activity These use different mechanisms than L-DOPA Cocaine- dopamine transporter and norepinephrine transporter blocker

Antipsychotic Drugs A range of drugs that reduce dopamine activity have been found useful in the treatment of schizophrenia and other disorders I.E. Valium

Role in Parkinson's Disease Parkinson's Disease has been related to the loss of dopamine secreting neurons in the midbrain called the substantia nigra. The projection of dopamine neurons from the substantia nigra pars compacta to the dorsal striatum plays a significant role in the control of motor function and in learning new motor programs. These neurons are especially vulnerable to damage and when a large fraction of them die, the result is PD. The administration of L-DOPA, the metabolic precursor for dopamine, is a treatment that cannot restore the dopamine cells that have been lost, but causes the remaining cells to produce more dopamine to compensate for what's lost.

Help Received Wikipedia